Logo for Akeso Inc

Akeso Inc Investor Relations Material

Latest events

Logo for Akeso Inc

H1 2024

28 Aug, 2024
Logo for Akeso Inc

H2 2023

18 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Akeso Inc

Access all reports
Akeso Inc is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of innovative therapies. The company focuses on oncology, immunology, and other therapeutic areas, utilizing its proprietary research platforms to develop monoclonal antibody drugs. The company is headquartered in Zhongshan, China, and its shares are listed on the SEHK.